CD4 and allergic asthma: By combining the administration of B. breve with non-digestible oligosaccharides in a chronic asthma murine model, Sagar et al[22] found that this specific combination was beneficial for allergic asthma, possibly via the induction of CD4+CD25+Foxp3+Treg cell response.